Twist Bioscience Corp at Barclays Global Healthcare Conference Transcript
I'm Luke Sergott, I cover life sciences tools and diagnostics here at Barclays. It's my pleasure to have Emily Leproust, the CEO of Twist; and Jim Thorburn, the CFO. So we're already kind of 30 seconds over. So when I say we just started jumping into that stock -- the shock clock. So I don't know.
Questions & Answers
I look at where the business is now versus where it was in 2018 and I look at where the stock is now versus where it was in 2018, and there's a massive disconnect here. Can you walk through how you see -- I mean the business is from -- it's 6x the size it was back then? Talk about the evolution here and really the forward trajectory as you see it from the business as it is today, versus where it's trading.
Yes. I mean in 2018, at the time of the IPO, the
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
